Results 31 to 40 of about 1,599,346 (327)

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need.

open access: yesBlood, 2022
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with historically poor outcomes and no worldwide consensus treatment approach.
N. Pemmaraju   +59 more
semanticscholar   +1 more source

Acute liver failure precipitated by acute Budd‐Chiari syndrome and complete portal vein thrombosis

open access: yesClinical Case Reports, 2021
Acute Budd‐Chiari syndrome and complete portal vein thrombosis are important features of myeloproliferative neoplasm that may occur simultaneously, resulting in acute liver failure.
Yuji Suzuki   +3 more
doaj   +1 more source

Liver transplantation for metastatic wild-type gastrointestinal stromal tumor in the era of molecular targeted therapies: report of a first case. [PDF]

open access: yes, 2019
The gastrointestinal stromal tumor (GIST) is a digestive neoplasm of mesenchymal lineage. The treatment strategy for receptor tyrosine kinase-mutated GISTs is well defined. Wild-type GISTs (WT-GISTs) respond unsatisfactorily to specific kinase inhibitors.
Benedetti Cacciaguerra, Andrea   +8 more
core   +3 more sources

American Journal of Transplantation / Successful kidney transplantation in a patient with pre‐existing chronic myeloid leukemia treated with imatinib [PDF]

open access: yes, 2021
Active malignancy is an absolute contraindication to kidney transplantation. As for chronic myeloid leukemia (CML), a Philadelphia chromosome‐positive myeloproliferative neoplasm, the introduction of tyrosine kinase inhibitors has transformed CML from a ...
Webersinke, Gerald   +5 more
core   +1 more source

Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation

open access: yesJAAD Case Reports, 2017
ALL: acute lymphoblastic leukemia BPDCN: blastic plasmacytoid dendritic cell neoplasm CVAD: cyclophosphamide, vincristine, doxorubicin, dexamethasone CVAD A1B: cyclophosphamide, vincristine, doxorubicin, dexamethasone alternating with methotrexate and ...
I. Amitay-Laish   +5 more
semanticscholar   +1 more source

Spindle Cell Neoplasm with Hyperbilirubinemia in a Renal Transplant Recipient: A Rare Case Report [PDF]

open access: yes, 2018
The risk of neoplasm increases after transplantation in patients with organ transplantation. Immunosuppressive treatments or oncogenic viruses are major risk factors.
Ö. İbrahim Karahan   +17 more
core   +1 more source

Predicting the course of hematopoietic neoplasm through oral bacterial examination [PDF]

open access: yes, 2022
Many medical institutions have recently conducted studies on the relationship between patients with hematopoietic neoplasms and oral cavity. Statistical analysis of the bacterial populations was performed in this study to identify how oral microflora and
ONO, Kaori   +11 more
core   +2 more sources

Oral carcinoma development after 23 years of renal transplantation

open access: yesAutopsy and Case Reports, 2019
Renal transplant patients are treated with immunosuppressive drugs that decrease the effectiveness of the immune system, making them more prone to developing cancer.
Isabel Schausltz Pereira Faustino   +4 more
doaj   +1 more source

Malignant neoplasms following bone marrow transplantation [PDF]

open access: yesBlood, 1996
We undertook an analysis of 2,150 recipients of bone marrow transplant (BMT) at the University of Minnesota to determine the incidence of post- BMT malignant neoplasms (MNs). Fifty-one patients developed 53 MNs, compared with 4.3 expected from general population rates (standardized incidence ratio [SIR], 11.6, 95% confidence interval [CI], 8.2–14.5 ...
S, Bhatia   +8 more
openaire   +2 more sources

Hepatic epithelioid hemangioendothelioma successfully treated with living donor liver transplantation: A case report and literature review

open access: yesClinical Case Reports, 2020
Hepatic epithelioid hemangioendothelioma is a rare neoplasm with a variable malignant potential and a high risk of recurrence. No general treatment guidelines have been established.
Sotaro Fukuhara   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy